Agiliti Surgical, Inc.
$17.5K 311 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Body Vision Medical Inc.
Body Vision Medical Inc. reported $17,461.63 across General Payments, Research, and Ownership to 98 physicians and teaching hospitals across 98 transactions.
- $17.5K Below-median payer
- All-tracks total
- 98 Below-median volume
- Transactions
- 98 Below-median reach
- Recipients
- −$18.4K
- General Payments vs PY2023
Body Vision Medical Inc. reported $17,461.63 across all CMS Open Payments tracks (General + Research + Ownership) to 98 physicians and teaching hospitals in Program Year 2024 - ranking #1556 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $17,461.63, averaging $178.18 per recipient.
How Body Vision Medical Inc.'s $17.5K all-tracks total breaks down
Body Vision Medical Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
10/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer body-vision-medical-inc Body Vision Medical Inc.
$17.5K · #1556/1,925 · 0.0% industry · PY2024
- TOT $17.5K
- RANK #1556
- SHARE 0.0%
- TXN 98
- RCP 98
- CAT 3
- GEN $17.5K
- ΔGEN −$18.4K
- TOP1 41.0%
- PY 2024
Volume peers
Nearest volume peer: Agiliti Surgical, Inc. ($17.5K)
Body Vision Medical Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Body Vision Medical Inc.'s CMS-reported General Payments decreased by $18.4K (−51.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BODY VISION MEDICAL INC.PY2023: BODY VISION MEDICAL INC.PY2024: Body Vision Medical Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $35,832.87
- PY2024
- $17,461.63
What the Data Shows for Body Vision Medical Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Body Vision Medical Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
6 transactions worth $6.5K make "Travel and Lodging" the top general-payment category in the 3-category breakdown below, 37.4% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Body Vision Medical Inc. made 3 types of general payments. "Travel and Lodging" is the largest category at $6.5K, 37.4% of General Payments.
How Body Vision Medical Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $6.5K | 6 | 37.4% |
| Consulting Fee | $6.1K | 5 | 34.9% |
| Food and Beverage | $4.8K | 87 | 27.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $14,019.57 (80.3%) of $17,461.63 in this company's General Payments records across 49 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Body Vision Medical Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Joseph Cicenia MD
$7,156.44 across 9 reported transactions
- 2
Sonali Sethi MD
$3,151.36 across 12 reported transactions
- 3
Michael Machuzak MD
$2,013.77 across 4 reported transactions
- 4
Ammar Alqaid MD
$860.35 across 6 reported transactions
- 5
Sujith Cherian MD
$837.65 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Body Vision Medical Inc. ranks #1556 of 1,925 by total payments (bottom 19% by spend) but is notably more concentrated than that alone would suggest -- #717 of 1,838 by HHI (top 39% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- CorMedix Inc. : $120.2K total payments, HHI 2228
- Peter Brasseler Holdings, LLC : $2.8M total payments, HHI 2223
- Paragonix Technologies, Inc. : $2.6M total payments, HHI 2220
- Freudenberg Medical, LLC : $88.80 total payments, HHI 2216
- Servier BioInnovation : $2.1K total payments, HHI 2211
- Endovascular Engineering Inc. : $44.3K total payments, HHI 2208
- Body Vision Medical Inc. (this company) : $17.5K total payments, HHI 2201
- Zevra Therapeutics Inc : $34.8K total payments, HHI 2200
- Prexion, Inc. : $31.5K total payments, HHI 2195
- HT Medical, LLC : $28.7K total payments, HHI 2191
- Endogastric Solutions, Inc : $196.7K total payments, HHI 2176
- FUKUDA DENSHI Co., Ltd. : $8.8K total payments, HHI 2176
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Body Vision Medical Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Body Vision Medical Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Body Vision Medical Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Polymedco, LLC
$17.5K 6 recipients
Compare payment profiles
Helios Cardio Inc
$17.4K 29 recipients
Compare payment profiles
Promega Corporation
$17.3K 24 recipients
Compare payment profiles
b2d Marketing
$17.6K 1 recipients
Compare payment profiles
Afaxys, Inc.
$17.3K 28 recipients
Compare payment profiles
Put this to use
Body Vision Medical Inc. ranks #1556 of 1,925 by all-tracks total payments, led by "Travel and Lodging".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Travel and Lodging" spend across every manufacturer, not just Body Vision Medical Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.